Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Alnylam Pharmaceuticals Inc. (ALNY)

75.37   -0.52 (-0.69%) 07-19 16:00
Open: 75.95 Pre. Close: 75.89
High: 75.95 Low: 74.75
Volume: 1,334,910 Market Cap: 8030M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 76.062 - 76.445 76.445 - 76.76
Low: 73.86 - 74.268 74.268 - 74.603
Close: 74.772 - 75.412 75.412 - 75.938

Technical analysis

as of: 2019-07-22 12:36:13 AM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 89.13     One year: 104.10
Support: Support1: 72.00    Support2: 69.34
Resistance: Resistance1: 76.31    Resistance2: 89.13
Pivot: 73.10
Moving Average: MA(5): 74.19     MA(20): 72.72
MA(100): 78.70     MA(250): 82.78
MACD: MACD(12,26): 0.72     Signal(9): 0.38
Stochastic oscillator: %K(14,3): 79.84     %D(3): 76.99
RSI: RSI(14): 57.50
52-week: High: 124.22  Low: 60.27  Change(%): -28.8
Average Vol(K): 3-Month: 97589  10-Days: 75555

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ALNY has closed below upper band by 6.5%. Bollinger Bands are 52.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to ALNY's normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 19 Jul 2019 16:18:38 Z
Horizon's NDA for Procysbi New Dosage Form Accepted by FDA

Thu, 18 Jul 2019 14:08:24 Z
Analysts Forecast 10% Gains Ahead For VONV

Thu, 11 Jul 2019 15:20:33 Z
Adverum (ADVM) Jumps: Stock Rises 5.1%

Thu, 11 Jul 2019 15:19:46 Z
Horizon Therapeutics Files BLA to FDA for Eye Disease Drug

Thu, 11 Jul 2019 00:07:34 Z
Kadmon Initiates Dosing in Study for Systemic Sclerosis Drug

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 100.17
Shares Float (M) 105.62
% Held by Insiders 10.78
% Held by Institutions 88.18
Shares Short (K) 5390
Shares Short P. Month (K)

Stock Financials

EPS -7.870
EPS Est. Current Year -5.200
EPS Est. Next Year -5.330
EPS Est. Next Quarter -1.360
Forward EPS -5.580
Book Value (p.s.) 14.540
PEG Ratio -0.19
Profit Margin
Operating Margin -991.92
Return on Assets (ttm) -27.2
Return on Equity (ttm) -48.6
Qtrly Rev. Growth 52.0
Gross Profit (p.s.) 0.730
Sales Per Share
EBITDA (p.s.) -8.392
Qtrly Earnings Growth
Operating Cash Flow (M) -595.46
Levered Free Cash Flow (M) -508.98

Stock Valuations

P/E -9.58
P/E Growth Ratio -0.01
P/BV 5.18
P/S 8882132992.00
P/CF -12.68

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.